Dr. Jeffrey R. Jay, M.D. »

Immunitybio shares owned by Dr. Jeffrey R. Jay, M.D.

Quarter-by-quarter ownership of Immunitybio (IBRX) shares owned by Dr. Jeffrey R. Jay, M.D. from 13F filings

Historical chart of Dr. Jeffrey R. Jay, M.D. investment in Immunitybio

Tip: Access up to 7 years of quarterly data

All positions including Immunitybio held by Dr. Jeffrey R. Jay, M.D. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunitybio by Dr. Jeffrey R. Jay, M.D.

Quarter filed Position value Share count Share price at filing
2026-03-31 $23M 3.0M 7.67

More positions owned by Dr. Jeffrey R. Jay, M.D.

Apogee Therapeutics (APGE)
Vor Biopharma Com New (VOR)
Zura Bio Class A Ord Shs (ZURA)
Amylyx Pharmaceuticals (AMLX)
Immunitybio Put Option (IBRX)
Nektar Therapeutics Com New (NKTR)
Sol-gel Technologies Shs New (SLGL)
Alumis (ALMS)
Bright Minds Biosciences Com New (DRUG)
Annexon (ANNX)
Kalvista Pharmaceuticals (KALV)
Immunovant (IMVT)
Jade Biosciences Com New (JBIO)
Contineum Therapeutics Cl A (CTNM)
Zenas Biopharma (ZBIO)

View all positions for Dr. Jeffrey R. Jay, M.D.

Top funds holding Immunitybio

Vanguard Group
BlackRock
State Street Corporation
Vanguard Portfolio Management
Vanguard Capital Management
D. E. Shaw & Co
Geode Capital Management
Susquehanna International
Citadel Advisors
Two Sigma Investments
LMR Partners
Morgan Stanley
Hrt Financial
Woodline Partners
Goldman Sachs Group

View all funds holding Immunitybio